Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Zydus Cadila files IND application for ZYIL1, NLRP3 inflammasome inhibitor

expresspharmaNovember 05, 2020

Tag: Zydus Cadila , ZYIL1 , NLRP3 , COVID-19

PharmaSources Customer Service